Results 121 to 130 of about 7,033,015 (228)

Discovery of Chiral N,N-Disubstituted Trifluoro-3-amino-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein

open access: yes, 2016
Discovery of Chiral N,N-Disubstituted Trifluoro-3-amino-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer ...
Deborah M. Heuvelman (3011085)   +15 more
core   +1 more source

Msp1 Polymorphism of Cholesteryl Ester Transfer Protein in Patients with Hypercholesterolemia

open access: yesپزشکی بالینی ابن سینا, 2013
Introduction & Objective: It has been shown that there is a correlation between cholesterol con-centration and coronary heart disease (CHD). Cholesteryl ester transfer protein (CETP) plays a central role in lipoproteins metabolism and it has been ...
Taghi Hassanzadeh   +4 more
doaj  

Anacetrapib: potential for the prevention and treatment of coronary heart disease

open access: yesResearch Reports in Clinical Cardiology, 2013
Dylan L Steen,1 Amit V Khera,2 Christopher P Cannon1 1TIMI Study Group, Cardiovascular Division, 2Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA Abstract: Despite major advances in cardiovascular care in recent decades ...
Steen DL, Khera AV, Cannon CP
doaj  

Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma

open access: yes, 1992
Plasma cholesteryl ester transfer protein (CETP) facilitates the net transfer and exchange of cholesteryl ester (CE), triglyceride (TG), and phospholipids between lipoproteins.
Hiroyuki Aral   +2 more
core  

Structure-based mechanism and inhibition of cholesteryl ester transfer protein. [PDF]

open access: yesCurr Atheroscler Rep, 2023
Xue H, Zhang M, Liu J, Wang J, Ren G.
europepmc   +1 more source

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

open access: yes, 2012
Marta A Miyares, Kyle DavisPharmacy Department, Jackson Memorial Hospital, Miami, FL, USAAbstract: Cardiovascular disease (CVD) is responsible for significant morbidity and mortality within the United States and worldwide.
Davis K, Miyares MA
core  

Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein. [PDF]

open access: yesJ Lipid Res, 2023
Ji A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy